Poietis NGB-R Bioprinter
This is a laboratory bioprinter that deposits living cells with a laser, housed in a tall enclosure with a glass front. The 148,063 polygons detail the cabinet panels, the inner print stage, the control screen and the access door. Its 153,327 vertices outnumber the faces by a small margin, consistent with clean hard surface modeling throughout.
Made to TurboSquid's CheckMate specification, the printer comes at real scale with clearly named, logically grouped parts. The UV layout is overlap free, so warning labels, screen content and brushed metal detail can be added. Glass panels are separate objects, which makes it easy to show the print head working inside.
A trio of rigged versions, each $99, open the door and move the stage, set up for different animation packages. Introduced in 2025, it suits biotech facility renders, regenerative medicine explainers and laboratory planning work. Placed in a clean room under cool light, the machine signals cutting edge research at first glance.
Questions About This Model
Which industries use the Poietis NGB-R Bioprinter model?
Medical, Simulation and Film & Video Production are the primary industries on this listing. The license, however, is Editorial Uses Only: the model depicts a real branded product, so it may appear in editorial work in those fields, but not in advertising or in products for sale.
What should I search for to find models like the Poietis NGB-R Bioprinter?
Useful search terms are ngb-r, poietis and bioprinter. Browsing the Medical category shows the closest alternatives at a range of prices.
Does the Poietis NGB-R Bioprinter model include materials and textures?
The product page states what ships with each format. Textures, when present, come inside the download rather than as a separate purchase. See the listing for the exact contents.
Can the Poietis NGB-R Bioprinter model be used in a commercial project?
No. The model depicts a real branded product, so TurboSquid lists it under the Editorial Uses Only license. It may be used in news, commentary, education, personal projects and similar editorial contexts, but not in advertising, on merchandise or in any product offered for sale. See our license guide.